Equities

Yabao Pharmaceutical Group Co Ltd

600351:SHH

Yabao Pharmaceutical Group Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CNY)5.25
  • Today's Change-0.06 / -1.13%
  • Shares traded5.73m
  • 1 Year change-36.21%
  • Beta1.3230
Data delayed at least 15 minutes, as of Sep 13 2024 08:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
REVENUE AND GROSS PROFIT
Total revenue2,9102,7182,764
OPERATING EXPENSES
Cost of revenue total1,2371,2111,087
Selling, general and admin. expenses, total1,2161,1461,270
Depreciation/amortization666056
Unusual expense(income)8357(6.15)
Other operating expenses, total(33)(25)(14)
Total operating expense2,6832,5952,561
Operating income226124203
Other, net(6.64)2.94(0.91)
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes219126202
Provision for income taxes392118
Net income after taxes180105184
Minority interest200.053.33
Net income before extra. Items200105187
Total extraordinary items------
Net income200105187
Inc.avail. to common excl. extra. Items200105187
Inc.avail. to common incl. extra. Items200105187
EPS RECONCILIATION
Basic/primary weighted average shares768770770
Basic/primary eps excl. extra items0.260.140.24
Basic/primary eps incl. extra items0.260.140.24
Dilution adjustment------
Diluted weighted average shares768770770
Diluted eps excl. extra items0.260.140.24
Diluted eps incl. extra items0.260.140.24
COMMON STOCK DIVIDENDS
DPS - common stock primary issue0.150.050.08
Gross dividend - common stock1083962
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental121923
SUPPLEMENTAL INCOME
Depreciation, supplemental147148154
Total special items8458(5.43)
NORMALISED INCOME
Normalized income before taxes303184196
Effect of special items on income taxes159.70(0.48)
Income tax excluding impact of special items543117
Normalized income after tax249153179
Normalized income avail. to common268153182
Basic normalized EPS0.350.200.24
Diluted normalized EPS0.350.200.24
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.